article thumbnail

Herd immunity is nice – but what about me?

pharmaphorum

Shahrokh Shabahang discusses why we need a personalised approach to COVID-19 immunity testing. While these numbers do tell us something about the relative immunity of the population writ large, they don’t tell us anything about our own, personal immune profiles. What does that mean in real-world terms?

article thumbnail

Temperature-stable tuberculosis vaccine induces immune response

European Pharmaceutical Review

Investigators assessed whether administering a temperature-stable vaccine containing both ID93 and GLA-SE in a single vial would be as effective at inducing an immune response as a regimen in which non-thermostable ID93 and liquid GLA-SE are held in two vials and combined prior to injection. However, Sagawa et al.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Targeted treatments for childhood febrile illnesses possible with new immune cell insights

Hospital Pharmacy Europe

A study has identified subtle changes in how immune cells respond to different severe febrile illnesses in children, which could lead to improved treatments. In the clinic currently, our treatments for dysfunctional immunity are poor and not targeted to individual children.

article thumbnail

Gritstone bio trumpets first data for ‘multivariant’ COVID jab

pharmaphorum

A COVID-19 vaccine that could work against multiple variants of the coronavirus – developed by US biotech Gritstone bio – has generated encouraging immune response data in its first clinical trial. “With new variants – like Omicron and B.1.640.2

Vaccines 126
article thumbnail

Opinion: How to separate sound wellness solutions from seductive snake oil

STAT

Challenged public health communication fueled skepticism in science and medicine, compelling consumers to seek influencer-led health solutions to boost immunity, defy disease, and perhaps contest aging altogether.

article thumbnail

Science Summarised: NF2 and Sporadic Vestibular Schwannoma

NF2 BioSolutions

[Image Description] Paper header for paper titled “The comparable tumour microenvironment in sporadic and NF2-related schwannomatosis vestibular schwannoma” by Gregory et al 2023, published in Brain Communications. Usually, immune cells function to protect the body by clearing infections and abnormal cells (like tumour cells).

article thumbnail

Grace’s 3 Years as an NF2 BioSolutions UK PhD Student

NF2 BioSolutions

I have enjoyed every moment, and I have made the most of all the opportunities to pass my way through the University of Manchester, NF2 research community and the Charity, all of whom have driven this research forward. Although VS and meningioma are both brain tumours in NF2, their immune cells act differently. So what have we found?